Atlas Trials

Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock

Clinical trial NCT06404424 · COMPLETED

Trial details

NCT number
NCT06404424
Sponsor
Efferon JSC
Status
COMPLETED
Study type
OBSERVATIONAL
SepsisSeptic Shock
Start date
2022-05-01
Primary completion
2023-12-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.